HomeInsightsStock Comparison

Blue Jet Healthcare Ltd vs Windlas Biotech Ltd Stock Comparison

Blue Jet Healthcare Ltd vs Windlas Biotech Ltd Stock Comparison

Last Updated on: Aug 02, 2025

Key Highlights

  • The Latest Trading Price of Blue Jet Healthcare Ltd is ₹ 795.7 as of 01 Aug 15:30.
  • The P/E Ratio of Blue Jet Healthcare Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Windlas Biotech Ltd changed from 12 on March 2022 to 35.8 on March 2025 . This represents a CAGR of 31.42% over 4 years.
  • The Market Cap of Blue Jet Healthcare Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Windlas Biotech Ltd changed from ₹ 457.9 crore on March 2022 to ₹ 2176 crore on March 2025 . This represents a CAGR of 47.65% over 4 years.
  • The revenue of Blue Jet Healthcare Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Windlas Biotech Ltd for the Mar '25 is ₹ 207.64 crore as compare to the Dec '24 revenue of ₹ 199.13 crore. This represent the growth of 4.27%.
  • The ebitda of Blue Jet Healthcare Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Windlas Biotech Ltd for the Mar '25 is ₹ 30.49 crore as compare to the Dec '24 ebitda of ₹ 28.74 crore. This represent the growth of 6.09%.
  • The net profit of Blue Jet Healthcare Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Windlas Biotech Ltd changed from ₹ 12.07 crore to ₹ 16.28 crore over 8 quarters. This represents a CAGR of 16.14% .
  • The Dividend Payout of Blue Jet Healthcare Ltd changed from 10.59 % on March 2024 to 0 % on March 2025 . This represents a CAGR of -100.00% over 2 yearsThe Dividend Payout of Windlas Biotech Ltd changed from 19.79 % on March 2022 to 20.04 % on March 2025 . This represents a CAGR of 0.31% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Blue Jet Healthcare Ltd

  • Blue Jet Healthcare Limited was originally incorporated as Jet Chemicals Private Limited,' at Mumbai, dated December 7, 1968.
  • The Company name was changed to Blue Jet Healthcare Private Limited', and a fresh Certificate of Incorporation dated December 30, 2020, was issued by the Registrar of Companies, Mumbai.
  • Subsequently, the status got converted into a Limited Company and its name was changed to Blue Jet Healthcare Limited' on May 18, 2022. The Company is a global, science-led, pharmaceutical company evolved as strategic partner for Collaboration, Development & Manufacturing of Advance Pharmaceutical Intermediates and API. It has operations organized into three product categories, contrast media intermediates, high- intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs).

About Windlas Biotech Ltd

  • Windlas Biotech Limited, formerly known as Windlas Biotech Private Limited was incorporated in 2001.
  • The Company got converted from a Private Limited to a Public Limited Company and the name of the Company was changed to Windlas Biotech Limited'.
  • A fresh Certificate of Incorporation dated April 15, 2021, granted by the Registrar of Companies, Uttarakhand at Dehradun. The Company is engaged in manufacturing and trading of pharmaceutical products.
  • Their manufacturing plants are located at Dehradun in Uttarakhand.
  • It has three distinct strategic business verticals (SBVs) mainly comprising of CDMO services and products; domestic trade generics and over-the-counter (OTC) brands; and exports. The Company commenced operations at Dehradun Plant -IV in 2010.

Blue Jet Healthcare Ltd News Hub

News

Board of Blue Jet Healthcare approves acquisition of land for new manufacturing unit

The Board of Blue Jet Healthcare at its meeting held on 31 July 2025 has approved the prop...

Read more

31 Jul 2025 19:35

News

Blue Jet Healthcare Ltd leads losers in 'B' group

Arfin India Ltd, Ideaforge Technology Ltd, Jana Small Finance Bank Ltd and Super Spinning ...

Read more

23 Jul 2025 14:45

News

Blue Jet Healthcare Ltd leads losers in 'B' group

Orissa Bengal Carrier Ltd, Megastar Foods Ltd, Goodluck India Ltd and Quadrant Future Tek ...

Read more

22 Jul 2025 14:45

News

Blue Jet Healthcare hits the floor as Q1 PAT tumbles 17% QoQ to Rs 91 cr

On a year on year basis, the company's net profit and revenue jumped 141.38% and 117.79%, ...

Read more

22 Jul 2025 14:41

News

Blue Jet Healthcare to discuss results

Blue Jet Healthcare will hold a meeting of the Board of Directors of the Company on 22 Jul...

Read more

16 Jul 2025 10:59

News

Board of Blue Jet Healthcare recommends Final Dividend

Blue Jet Healthcare announced that the Board of Directors of the Company at its meeting he...

Read more

14 May 2025 14:45

Windlas Biotech Ltd News Hub

News

Windlas Biotech to convene AGM

Windlas Biotech announced that the 24th Annual General Meeting(AGM) of the company will be...

Read more

04 Jul 2025 16:39

News

Windlas Biotech Ltd Spurts 3.25%

Windlas Biotech Ltd rose 3.25% today to trade at Rs 927. The BSE Healthcare index is up 0....

Read more

19 Jun 2025 09:30

News

Windlas Biotech Ltd Slips 4.88%, BSE Healthcare index Shed 1.03%

Windlas Biotech Ltd fell 4.88% today to trade at Rs 923. The BSE Healthcare index is down ...

Read more

23 May 2025 09:30

News

Board of Windlas Biotech recommends final dividend

Windlas Biotech announced that the Board of Directors of the Company at its meeting held o...

Read more

22 May 2025 21:08

News

Windlas Biotech to announce Quarterly Result

Windlas Biotech will hold a meeting of the Board of Directors of the Company on 22 May 202...

Read more

15 May 2025 12:29

News

Windlas Biotech receives affirmation in credit ratings from ICRA

Windlas Biotech has received reaffirmation in credit ratings from ICRA at ICRA A+; Stable/...

Read more

08 Apr 2025 15:08

SWOT Analysis Of Blue Jet Healthcare Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Windlas Biotech Ltd

Strength

5

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Blue Jet Healthcare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Windlas Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Blue Jet Healthcare Ltd and Windlas Biotech Ltd

Which company has a larger market capitalization, Blue Jet Healthcare Ltd or Windlas Biotech Ltd?

Market cap of Blue Jet Healthcare Ltd is 13,802 Cr while Market cap of Windlas Biotech Ltd is 2,022 Cr

What are the key factors driving the stock performance of Blue Jet Healthcare Ltd and Windlas Biotech Ltd?

The stock performance of Blue Jet Healthcare Ltd and Windlas Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Blue Jet Healthcare Ltd and Windlas Biotech Ltd?

As of August 2, 2025, the Blue Jet Healthcare Ltd stock price is INR ₹795.7. On the other hand, Windlas Biotech Ltd stock price is INR ₹967.45.

How do dividend payouts of Blue Jet Healthcare Ltd and Windlas Biotech Ltd compare?

To compare the dividend payouts of Blue Jet Healthcare Ltd and Windlas Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions